Healthcare provider profile · identity verified

Larissa Lucas

Hospice and Palliative Care · CAMBRIDGE, MA · NPI 1205999752

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	1020	82
Mirtazapine	Mirtazapine	661	98
Levothyroxine Sodium	Levothyroxine Sodium	650	91
Atorvastatin Calcium	Atorvastatin Calcium	631	108
Furosemide	Furosemide	630	68
Trazodone Hcl	Trazodone Hcl	551	95
Potassium Chloride	Potassium Chloride	496	62
Sertraline Hcl	Sertraline Hcl	473	56
Metoprolol Succinate	Metoprolol Succinate	443	82
Amlodipine Besylate	Amlodipine Besylate	408	74
Gabapentin	Gabapentin	345	58
Tamsulosin Hcl	Tamsulosin Hcl	284	48
Quetiapine Fumarate	Quetiapine Fumarate	277	49
Pantoprazole Sodium	Pantoprazole Sodium	255	36
Lisinopril	Lisinopril	251	47
Omeprazole	Omeprazole	236	48
Metoprolol Tartrate	Metoprolol Tartrate	216	35
Xarelto	Rivaroxaban	207	15
Torsemide	Torsemide	206	37
Metformin Hcl	Metformin Hcl	195	30
Clopidogrel	Clopidogrel Bisulfate	184	23
Losartan Potassium	Losartan Potassium	179	30
Finasteride	Finasteride	172	24
Allopurinol	Allopurinol	151	22
Divalproex Sodium	Divalproex Sodium	150	23
Donepezil Hcl	Donepezil Hcl	150	25
Warfarin Sodium	Warfarin Sodium	142	19
Levetiracetam	Levetiracetam	121	16
Carbidopa-Levodopa	Carbidopa/Levodopa	119	19
Latanoprost	Latanoprost	117	18
Citalopram Hbr	Citalopram Hydrobromide	116	17
Carvedilol	Carvedilol	111	20
Jardiance	Empagliflozin	107	12
Duloxetine Hcl	Duloxetine Hcl	105	14
Midodrine Hcl	Midodrine Hcl	105	19
Rosuvastatin Calcium	Rosuvastatin Calcium	102	20
Famotidine	Famotidine	96	23
Memantine Hcl	Memantine Hcl	92	17
Methenamine Hippurate	Methenamine Hippurate	92	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	91	13
Amiodarone Hcl	Amiodarone Hcl	89	13
Digoxin	Digoxin	86	12
Januvia	Sitagliptin Phosphate	86	suppressed
Prednisone	Prednisone	86	19
Fluticasone Propionate	Fluticasone Propionate	85	22
Escitalopram Oxalate	Escitalopram Oxalate	83	14
Pravastatin Sodium	Pravastatin Sodium	78	11
Olanzapine	Olanzapine	77	12
Atenolol	Atenolol	76	suppressed
Simvastatin	Simvastatin	73	18
Fluoxetine Hcl	Fluoxetine Hcl	67	11
Triamcinolone Acetonide	Triamcinolone Acetonide	64	19
Spironolactone	Spironolactone	62	17
Lamotrigine	Lamotrigine	60	suppressed
Timolol Maleate	Timolol Maleate	60	suppressed
Labetalol Hcl	Labetalol Hcl	59	suppressed
Cephalexin	Cephalexin	58	26
Glipizide	Glipizide	58	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	57	25
Lantus	Insulin Glargine,hum.Rec.Anlog	52	12
Permethrin	Permethrin	51	28
Ondansetron Hcl	Ondansetron Hcl	48	30
Clozapine	Clozapine	47	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	47	suppressed
Hydralazine Hcl	Hydralazine Hcl	45	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	suppressed
Methotrexate	Methotrexate Sodium	44	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Clonidine Hcl	Clonidine Hcl	42	suppressed
Tradjenta	Linagliptin	42	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	41	11
Alendronate Sodium	Alendronate Sodium	39	suppressed
Risperidone	Risperidone	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	23
Bupropion Hcl Sr	Bupropion Hcl	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	15
Lactulose	Lactulose	34	11
Buspirone Hcl	Buspirone Hcl	33	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	33	suppressed
Glipizide Er	Glipizide	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	18
Baclofen	Baclofen	32	suppressed
Cholestyramine	Cholestyramine (With Sugar)	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	29	11
Nyamyc	Nystatin	29	15
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Calcitriol	Calcitriol	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Clobetasol Propionate	Clobetasol Propionate	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Ceftriaxone	Ceftriaxone Sodium	26	19
Nuedexta	Dextromethorphan Hbr/Quinidine	26	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	12
Cefpodoxime Proxetil	Cefpodoxime Proxetil	25	19
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	25	suppressed
Anastrozole	Anastrozole	24	suppressed
Lubiprostone	Lubiprostone	24	suppressed
Valsartan	Valsartan	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Lidocaine Hcl	Lidocaine Hcl	23	18
Rivastigmine	Rivastigmine	23	suppressed
Insulin Lispro	Insulin Lispro	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	14
Celecoxib	Celecoxib	21	suppressed
Erythromycin	Erythromycin Base	21	11
Sodium Chloride	0.9 % Sodium Chloride	21	suppressed
Spiriva Handihaler	Tiotropium Bromide	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Trospium Chloride	Trospium Chloride	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Folic Acid	Folic Acid	19	suppressed
Novolog	Insulin Aspart	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	18	suppressed
Budesonide Ec	Budesonide	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Lumigan	Bimatoprost	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Brinzolamide	Brinzolamide	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Alclometasone Dipropionate	Alclometasone Dipropionate	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	11
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Azithromycin	Azithromycin	15	12
Oseltamivir Phosphate	Oseltamivir Phosphate	15	14
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Admelog	Insulin Lispro	14	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Atropine Sulfate	Atropine Sulfate	13	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Tacrolimus	Tacrolimus	13	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Fiasp	Insulin Aspart (Niacinamide)	12	suppressed
Letrozole	Letrozole	12	suppressed
Linzess	Linaclotide	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	12	suppressed
Tivicay	Dolutegravir Sodium	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Phenytoin	Phenytoin	11	suppressed
Santyl	Collagenase Clostridium Hist.	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error